List of works - Lorenzo G. Mantovani

A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care

scientific article published on 9 March 2010

A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment.

scientific article

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

scientific article published in April 2011

Allergic rhinitis in the Italian population evaluated through the national database of general practitioners

scientific article published on 01 May 2007

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom

scientific article published on 11 January 2008

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

scientific article published in November 2011

Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective

scientific article

Burden of acute myocardial infarction

scientific article published on 24 May 2011

Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases

scientific article

Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy

scientific article published in May 1998

Cardiac resynchronization therapy: a cost or an investment?

Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy

scientific article published on 21 November 2014

Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study

scientific article

Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids

scientific article

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

scientific article published on 19 June 2003

Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study.

scientific article published on 16 April 2015

Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.

scientific article published on July 2015

Cost-effectiveness analysis of new drugs for chronic hepatitis C: the importance of updating utility values

scientific article published on 20 January 2015

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

scientific article published on 27 May 2008

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

scientific article published on July 2006

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors

scientific article published in January 2007

Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario

scientific article published in May 2011

Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment

scientific article

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

scientific article published on 24 February 2015

Economic evaluation in cardiology

scientific article published on 01 May 2011

Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

scientific article published on 29 February 2016

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016

scientific article published on 01 December 2018

Haemophilia prophylaxis: how can we justify the costs? ⬇️

scientific article published on April 17, 2012

Health economic models in hemophilia A and utility assumptions from a clinician's perspective

scientific article published on 14 May 2015

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.

scientific article published on 7 February 2013

Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology

scientific article

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

scientific article

Healthcare costs associated with hepatocellular carcinoma and the value of care.

scientific article

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

scientific article published on 17 August 2015

Is preventive medical care worth the cost?

scientific article published on 01 June 1997

Italian population-based values of EQ-5D health states.

scientific article published on 19 June 2013

KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting

scientific article published on 20 January 2014

Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis

scientific article

Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.

scientific article published in May 2006

Major diabetes complications have an impact on total annual medical cost of type 2 diabetes.

scientific article published in July 2004

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.

scientific article published on 10 July 2014

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

scientific article

Oral antiviral therapies are cost-effective vs. no treatment but indirect comparisons should be avoided

scientific article published on 07 October 2009

Patient preferences and willingness to pay for different options of anticoagulant therapy

scientific article

Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study

scientific article

Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs

article

Pharmacoeconomic Issues in Psoriatic Arthritis ⬇️

scientific article published on July 1, 2012

Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.

scientific article published on 6 January 2006

Present and future challenges in the treatment of haemophilia: the patient's perspective

scientific article

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

scientific article

Psoriatic arthritis: pharmacoeconomic considerations

scientific article published on 01 August 2009

Quality of life assessment in clinical practice in haemophilia treatment.

scientific article

Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

scientific article published in March 2006

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

scientific article

Real life studies and good clinical practice - Authors' reply

scientific article published in April 2016

Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.

scientific article published on 13 November 2007

Regarding "Exploring patient involvement in decision making for vascular procedures"

scientific article published on 01 June 2016

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions

scientific article published on 18 November 2015

Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.

scientific article

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study

article

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

scientific article

Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact

scientific article published on 16 June 2009

The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients

scientific article

The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Associazione Italiana Studi Psoriasi

scientific article published on 01 July 2001

The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature

scientific article published on December 2011

The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review.

scientific article published on January 2012

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.

scientific article

The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis

scientific article

The perspective of a pharmacoeconomic study: targeting for audiences ⬇️

scientific article published on May 1, 1997

The pharmacoeconomic impact of amlodipine use on coronary artery disease.

scientific article published in May 2006

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.

scientific article published on 24 August 2008

The social burden and quality of life of patients with haemophilia in Italy

scientific article

The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients.

scientific article

Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data

scientific article published on 12 December 2017

Uncovered needs in the management of inherited bleeding disorders in Italy

scientific article

XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis.

scientific article

List of works by Lorenzo G. Mantovani

A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care

A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment.

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

Allergic rhinitis in the Italian population evaluated through the national database of general practitioners

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective

Burden of acute myocardial infarction

Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases

Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy

Cardiac resynchronization therapy: a cost or an investment?

Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy

Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study

Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study.

Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.

Cost-effectiveness analysis of new drugs for chronic hepatitis C: the importance of updating utility values

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors

Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario

Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

Economic evaluation in cardiology

Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016

Haemophilia prophylaxis: how can we justify the costs? ⬇️

Health economic models in hemophilia A and utility assumptions from a clinician's perspective

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.

Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

Healthcare costs associated with hepatocellular carcinoma and the value of care.

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

Is preventive medical care worth the cost?

Italian population-based values of EQ-5D health states.

KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting

Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis

Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.

Major diabetes complications have an impact on total annual medical cost of type 2 diabetes.

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

Oral antiviral therapies are cost-effective vs. no treatment but indirect comparisons should be avoided

Patient preferences and willingness to pay for different options of anticoagulant therapy

Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study

Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs

Pharmacoeconomic Issues in Psoriatic Arthritis ⬇️

Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.

Present and future challenges in the treatment of haemophilia: the patient's perspective

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Psoriatic arthritis: pharmacoeconomic considerations

Quality of life assessment in clinical practice in haemophilia treatment.

Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Real life studies and good clinical practice - Authors' reply

Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.

Regarding "Exploring patient involvement in decision making for vascular procedures"

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions

Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact

The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients

The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Associazione Italiana Studi Psoriasi

The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature

The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review.

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.

The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis

The perspective of a pharmacoeconomic study: targeting for audiences ⬇️

The pharmacoeconomic impact of amlodipine use on coronary artery disease.

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.

The social burden and quality of life of patients with haemophilia in Italy

The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients.

Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data

Uncovered needs in the management of inherited bleeding disorders in Italy

XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis.